plasma
Z138; HEK293T
-
proliferation (promotes); apoptosis (inhibits); MAPK (other); other pathway/process (other)
RT-qPCR; Clinical Sample Validation; ROC Analysis; Survival Analysis; Transfection; CCK8; Bioinformatics Analysis
circCDYL had diagnostic value in distinguishing MCL patients from healthy controls (AUC = 0.856)
circCDYL is up-regulated in the plasma of mantle cell lymphoma patients and shows diagnostic potential (AUC 0.856). Functionally, circCDYL promotes proliferation of MCL Z138 cells, since circCDYL knockdown suppresses proliferation. The proposed mechanism is a bioinformatically predicted circCDYL-miRNA-mRNA/lncRNA regulatory network involving five highlighted miRNAs and targets including NOTCH1, ABCB1, TWIST1 and VEGFA.
0.6422
CircCDYL Serves as a New Biomarker in Mantle Cell Lymphoma and Promotes Cell Proliferation.
combined biological and clinical study